Home/Filings/4/0001127602-21-028310
4//SEC Filing

Brennan Troyen A 4

Accession 0001127602-21-028310

CIK 0000064803other

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 4:44 PM ET

Size

17.0 KB

Accession

0001127602-21-028310

Insider Transaction Report

Form 4
Period: 2021-11-01
Brennan Troyen A
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-11-01$90.00/sh28,159$2,534,310138,246.059 total
  • Exercise/Conversion

    Common Stock

    2021-11-01$58.34/sh+28,159$1,642,796166,405.059 total
  • Exercise/Conversion

    Stock Option

    2021-11-0128,15984,478 total
    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (28,159 underlying)
Holdings
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (80,803 underlying)
    80,803
  • Common Stock (restricted)

    4,805
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (21,894 underlying)
    21,894
  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01Common Stock (47,937 underlying)
    47,937
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (75,134 underlying)
    75,134
  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01Common Stock (53,772 underlying)
    53,772
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (99,344 underlying)
    99,344
Footnotes (8)
  • [F1]The number of shares subject to the option were calculated using a 30-day average price.
  • [F2]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F8]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001351402

Filing Metadata

Form type
4
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:44 PM ET
Size
17.0 KB